page_slug,page_title,parent_hub_name,parent_hub_url,hero_headline,hero_description,sub_services_title,sub_services_description,sub_service_1_icon,sub_service_1_title,sub_service_1_description,sub_service_1_link,sub_service_2_icon,sub_service_2_title,sub_service_2_description,sub_service_2_link,sub_service_3_icon,sub_service_3_title,sub_service_3_description,sub_service_3_link,sub_service_4_icon,sub_service_4_title,sub_service_4_description,sub_service_4_link,sub_service_5_icon,sub_service_5_title,sub_service_5_description,sub_service_5_link,sub_service_6_icon,sub_service_6_title,sub_service_6_description,sub_service_6_link,sub_service_7_icon,sub_service_7_title,sub_service_7_description,sub_service_7_link,sub_service_8_icon,sub_service_8_title,sub_service_8_description,sub_service_8_link,primary_content_title,primary_content_description,key_capabilities_title,capability_1_title,capability_1_description,capability_2_title,capability_2_description,capability_3_title,capability_3_description,capability_4_title,capability_4_description,capability_5_title,capability_5_description,capability_6_title,capability_6_description,why_choose_title,why_choose_description,why_choose_1_icon,why_choose_1_title,why_choose_1_description,why_choose_2_icon,why_choose_2_title,why_choose_2_description,why_choose_3_icon,why_choose_3_title,why_choose_3_description,cta_title,cta_description,cta_primary_button_text,cta_primary_button_link
heart-failure-testing,Heart Failure Testing Services | Synchrony Labs,Cardiovascular Disease Testing,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing,Heart Failure Testing Services,"Comprehensive preclinical validation for mechanical circulatory support devices including LVAD performance characterization, cardiac resynchronization therapy assessment, and hemodynamic testing under GLP compliance.",Complete Heart Failure Testing Services,"We provide specialized testing for mechanical circulatory support devices, addressing unique performance, biocompatibility, and durability requirements for each platform.",Heart,Heart Pump Testing,"Mechanical circulatory support device validation including pump performance characterization, flow dynamics assessment, and temporary cardiac support system evaluation.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-failure-testing/heart-pump-testing,Heart,LVAD Testing,"Left ventricular assist device validation with hemocompatibility assessment, pump durability protocols, and anatomical integration studies for bridge-to-transplant and destination therapy applications.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-failure-testing/lvad-testing,,,,,,,,,,,,,,,,,,,,,,,,,What We Test,"Heart failure devices sustain life when cardiac function deteriorates, requiring validation that demonstrates both mechanical performance and therapeutic benefit. LVADs must maintain continuous flow across varying preload and afterload conditions while preventing hemolysis, platelet activation, and thrombotic complications. Cardiac resynchronization therapy devices need precise pacing algorithms that restore ventricular synchrony and improve ejection fraction. Temporary support systems require rapid deployment validation and stable performance during acute decompensation events.

We evaluate pump performance using pressure-volume loop analysis and real-time flow monitoring that captures hemodynamic responses across physiological stress conditions. Our catheterization laboratories feature continuous cardiac output measurement, ventricular pressure monitoring, and echocardiographic imaging that tracks device-heart interactions throughout complete cardiac cycles. Hemocompatibility testing quantifies hemolysis indices, platelet function, and von Willebrand factor degradation using ISO 10993-4 protocols adapted for rotary blood pump assessment.

ISO 10993 biocompatibility standards guide chronic implantation assessment while device-specific protocols address pump durability, electrical performance validation for CRT systems, and anatomical integration for surgical implants. Whether validating next-generation continuous-flow LVADs, percutaneous temporary support devices, or biventricular assist systems, our GLP-compliant testing addresses both PMA pathway requirements and post-market surveillance objectives.",Key Testing Capabilities,Hemodynamic Performance Assessment,"Pressure-volume loop analysis quantifies ventricular function, stroke work, and cardiac output under varying pump speeds. Real-time monitoring captures preload sensitivity, afterload response, and flow pulsatility across physiological conditions.",Pump Performance Characterization,"Flow curve validation across pressure ranges evaluates pump efficiency, power consumption, and rotor speed stability. Testing protocols assess continuous-flow dynamics, pulsatile performance, and flow modulation capabilities for physiological adaptation.",Hemocompatibility and Blood Damage Assessment,"ISO 10993-4 compliant testing quantifies hemolysis indices, platelet activation markers, and von Willebrand factor degradation. Specialized protocols evaluate shear stress effects, thrombogenic potential, and anticoagulation requirements for chronic blood contact.",Durability and Accelerated Wear Testing,"Long-term durability protocols simulate years of continuous operation through accelerated cycling. Performance monitoring detects bearing wear, seal degradation, and rotor dynamics changes while validating backup power systems and alarm functions.",Cardiac Resynchronization Therapy Validation,"Biventricular pacing optimization uses echocardiography to assess ventricular synchrony improvement and ejection fraction enhancement. Lead positioning validation, pacing threshold characterization, and sensing algorithm verification address CRT-specific performance requirements.",Anatomical Integration and Biocompatibility,"Chronic implantation studies evaluate tissue response at pump-myocardium interfaces, cannula positioning stability, and healing patterns around device components. Histopathological analysis characterizes fibrosis, inflammation, and cellular responses using standardized scoring systems.",Why Choose Synchrony for Heart Failure Testing,Four decades of exclusive cardiovascular focus provides specialized infrastructure and proven regulatory expertise for life-sustaining cardiac devices that generic facilities cannot match.,Layers,Specialized Pump Testing Infrastructure,"Two catheterization laboratories equipped specifically for mechanical circulatory support evaluation feature continuous hemodynamic monitoring, pressure-volume loop analysis systems, and real-time flow measurement capabilities. Our mock circulation loops replicate physiological preload and afterload conditions while specialized test fixtures accommodate both implantable and percutaneous pump configurations across varying anatomical requirements.",Users,Heart Failure Device Expertise,"Founded by Duke University interventional cardiologists who pioneered advanced heart failure management techniques, our team understands ventricular mechanics, pump physiology, and hemodynamic optimization specific to mechanical circulatory support. This cardiovascular heritage translates to protocol designs that address FDA Class III device requirements including durability demonstration, hemocompatibility assessment, and the comprehensive safety validation life-sustaining devices demand.",Activity,Proven PMA Pathway Success,"Our data packages have supported successful FDA approvals for mechanical circulatory support devices across LVAD, BiVAD, and temporary support categories. We understand Class III device requirements including chronic biocompatibility demonstration through ISO 10993 compliance, pump durability validation, and the specific endpoints FDA expects for heart failure device submissions addressing both bridge-to-transplant and destination therapy applications.",Ready to Start Your Study?,"Our team is ready to discuss your heart failure device, regulatory pathway, and study requirements to optimize your path to FDA approval.",Schedule Consultation,https://harmonious-leadership-859682.framer.app/contact
heart-valve-testing,Heart Valve Testing Services | Synchrony Labs,Cardiovascular Disease Testing,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing,Heart Valve Testing Services,"Comprehensive preclinical testing for transcatheter and surgical heart valves with durability validation, deployment performance assessment, and hemodynamic testing.",Complete Heart Valve Testing Services,"We provide specialized testing for all major transcatheter heart valve platforms and surgical valves, addressing unique deployment, performance, and durability requirements for each design.",Heart,TAVR Testing,"Transcatheter aortic valve testing with deployment accuracy assessment, paravalvular leak quantification, and coronary flow preservation.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/tavr-testing,Grip,MitraClip Testing,Edge-to-edge mitral repair testing with precision grasping force validation and leaflet coaptation assessment.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/mitraclip-testing,Circle,Sapien Valve Testing,Balloon-expandable TAVR testing with crimping profile characterization and paravalvular leak assessment.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/sapien-valve-testing,Expand,Evolut Testing,Repositionable TAVR testing with nitinol frame behavior assessment and multiple deployment cycle validation.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/evolut-testing,Layers,Pascal Testing,Mitral repair device testing with independent leaflet grasping mechanics and broad paddle coaptation assessment.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/pascal-testing,Anchor,Tendyne Testing,Mitral replacement testing with apical tether tensioning validation and D-shaped frame accommodation assessment.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/tendyne-testing,Triangle,TriClip Testing,Tricuspid repair testing addressing leaflet heterogeneity and severe annular dilation challenges.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/triclip-testing,Hexagon,CoreValve Testing,Self-expanding aortic valve testing with nitinol framework validation and supra-annular positioning assessment.,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/heart-valve-testing/corevalve-testing,What We Test,"Heart valve devices face relentless mechanical demands opening and closing 100,000 times daily while maintaining hemodynamic performance that prevents heart failure progression. Transcatheter and surgical valves require comprehensive validation beyond basic durability testing. We evaluate deployment precision in challenging anatomies, quantify paravalvular leak across varying calcification patterns, and assess long-term structural integrity through accelerated wear protocols.

Our pulse duplicator systems replicate physiological conditions across left and right heart environments while advanced imaging captures valve positioning, leaflet motion, and regurgitation throughout complete cardiac cycles. From TAVR platforms requiring annular sealing validation to mitral repair devices demanding precise grasping force characterization, our protocols address the specific challenges each valve design presents.

ISO 5840 compliance guides our testing methodology while four decades of structural heart experience informs protocol development that addresses FDA expectations. Whether validating balloon-expandable TAVR crimping profiles or assessing edge-to-edge repair durability, our catheterization laboratories provide the specialized infrastructure and expertise valve development demands.",Key Testing Capabilities,Hemodynamic Performance Assessment,"Transvalvular gradient measurement, effective orifice area quantification, and flow pattern characterization using pulse duplicators with variable cardiac output and heart rate conditions",Durability and Fatigue Testing,Accelerated wear protocols through 200-400 million cycles representing 5-10 year equivalents with continuous performance monitoring detecting early structural deterioration,Deployment Mechanics Validation,"High-speed fluoroscopic imaging captures deployment dynamics while force sensors quantify radial strength, chronic outward force, and expansion characteristics across anatomical variations",Paravalvular Leak Quantification,Advanced flow measurement techniques evaluate sealing effectiveness with real-time leak detection during deployment enabling optimization of annular contact mechanisms,Biocompatibility and Thrombogenicity,ISO 10993-4 compliant hemocompatibility testing addresses blood-contacting device performance with specialized protocols evaluating thrombotic potential under varying anticoagulation scenarios,Advanced Imaging Integration,"Transesophageal echocardiography, high-resolution fluoroscopy, and intracardiac imaging provide comprehensive valve visualization throughout deployment and follow-up assessment periods",Why Choose Synchrony for Heart Valve Testing,Four decades of exclusive structural heart focus provides specialized infrastructure and proven regulatory expertise that generic cardiovascular facilities cannot match.,Layers,Specialized Valve Testing Infrastructure,"Two catheterization laboratories equipped specifically for structural heart procedures feature advanced transesophageal echocardiography, biplane fluoroscopy, and hemodynamic monitoring systems. Our pulse duplicator capabilities replicate physiological conditions across all cardiac valve positions while specialized deployment fixtures accommodate both balloon-expandable and self-expanding platforms.",Users,Structural Heart Device Expertise,"Founded by Duke University interventional cardiologists who pioneered transcatheter techniques, our team understands valve physiology, deployment challenges, and regulatory expectations specific to structural heart devices. This heritage translates to protocol designs that address FDA reviewer questions before they arise and testing strategies that optimize device performance.",Activity,Proven PMA Success Record,"Our data packages have supported successful FDA approvals for transcatheter heart valves across aortic, mitral, and tricuspid positions. We understand Class III device requirements including durability demonstration through ISO 5840 compliance, paravalvular leak assessment methodologies, and the specific endpoints FDA expects for structural heart device submissions.",Ready to Start Your Study?,"Our team is ready to discuss your valve device, regulatory pathway, and study requirements to optimize your path to FDA approval.",Schedule Consultation,https://harmonious-leadership-859682.framer.app/contact
structural-heart-testing,Structural Heart Testing Services | Synchrony Labs,Cardiovascular Disease Testing,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing,Structural Heart Testing Services,"Comprehensive preclinical validation for LAA closure devices, septal defect occluders, and transcatheter repair systems with deployment accuracy assessment, anatomical compatibility testing, and chronic tissue integration evaluation under GLP compliance.",Complete Structural Heart Testing Services,"We provide specialized testing for LAA closure systems, septal defect devices, and structural repair platforms, addressing unique deployment mechanics, anatomical variation, and chronic tissue integration requirements for each technology.",MapPin,LAA Closure Testing,"Left atrial appendage closure device validation with deployment accuracy assessment, occlusion effectiveness testing, and endothelialization progression monitoring across morphological variants.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/structural-heart-testing/laa-closure-testing,Eye,Watchman Device Testing,"Specialized Watchman LAA occluder validation with sizing algorithm verification, device stability assessment, and peridevice leak quantification for stroke prevention applications.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/structural-heart-testing/watchman-device-testing,Zap,Renal Denervation Testing,"Catheter-based renal denervation system validation including sympathetic nerve ablation verification, energy delivery characterization, and chronic reinnervation assessment for hypertension therapy.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/structural-heart-testing/renal-denervation-testing,,,,,,,,,,,,,,,,,,,,,What We Test,"Structural heart devices operate in anatomical environments where standard cardiovascular testing protocols fall short. LAA closure systems must seal appendages with chicken wing, cactus, cauliflower, and windsock morphologies while preventing peridevice leaks that compromise stroke protection. Septal defect occluders need stable positioning across varying defect geometries with tissue integration that creates permanent closure. Transcatheter repair platforms require precise deployment in moving cardiac structures while maintaining device stability throughout continuous cardiac cycles.

We evaluate deployment accuracy using high-resolution fluoroscopy and transesophageal echocardiography that captures device positioning throughout complete cardiac motion. Our catheterization laboratories feature specialized left atrial access capabilities, anatomical models representing morphological variations, and hemodynamic monitoring systems that assess device performance under physiological conditions. From device-tissue interface characterization to chronic endothelialization studies, our protocols address the specific challenges structural heart technologies present.

ISO 10993 biocompatibility standards guide chronic implantation assessment while device-specific protocols address deployment mechanics, anatomical compatibility across patient populations, and long-term tissue integration. Whether validating Watchman LAA occluders refined through dozens of studies, novel septal closure systems, or emerging transcatheter repair platforms, our GLP-compliant testing addresses both PMA pathway requirements and post-market surveillance objectives across structural heart device categories.",Key Testing Capabilities,Anatomical Compatibility Assessment,"Deployment validation across morphological variants using anatomically accurate models that replicate chicken wing, cactus, cauliflower, and windsock LAA configurations plus varying septal defect geometries. Advanced imaging provides detailed anatomical measurements and device sizing verification.",Deployment Mechanics Characterization,"High-resolution fluoroscopy and transesophageal echocardiography capture device deployment dynamics, positioning accuracy, and stability during cardiac motion. Specialized protocols assess delivery system performance, retrieval capabilities, and deployment consistency across anatomical variations.",Occlusion Effectiveness and Leak Assessment,"Advanced flow measurement techniques quantify LAA occlusion completeness, peridevice leak detection, and septal defect closure effectiveness. Real-time imaging during deployment enables sealing optimization while long-term studies validate permanent closure maintenance.",Chronic Tissue Integration Studies,"Extended observation protocols evaluate endothelialization progression, device-tissue interface healing, and biological integration patterns. Histopathological analysis characterizes tissue ingrowth, cellular responses, and complete endothelial coverage development using standardized scoring systems.",Device Stability and Durability Testing,"Cardiac cycle simulation assesses device positioning stability, anchoring mechanism integrity, and structural performance throughout extended physiological loading. Accelerated fatigue protocols characterize material durability and predict long-term device behavior.",Biocompatibility and Thrombogenicity Evaluation,ISO 10993-4 compliant hemocompatibility testing addresses blood contact requirements while specialized thrombogenicity protocols evaluate clot formation potential under atrial fibrillation flow patterns. Chronic biocompatibility studies assess tissue response and material integration over implant lifetime.,Why Choose Synchrony for Structural Heart Testing,Four decades of exclusive cardiovascular focus provides specialized infrastructure and proven regulatory expertise for complex structural heart devices that generic facilities cannot match.,Layers,Specialized Structural Heart Infrastructure,"Two catheterization laboratories equipped specifically for structural heart procedures feature transesophageal echocardiography, high-resolution fluoroscopy, and specialized left atrial access capabilities. Our anatomical model library spans LAA morphological variants and septal defect geometries while hemodynamic monitoring systems capture device-heart interactions throughout complete cardiac cycles.",Users,Structural Heart Device Expertise,"Founded by Duke University interventional cardiologists who pioneered transcatheter structural heart procedures, our team understands complex cardiac anatomy, deployment mechanics, and chronic tissue integration requirements. This cardiovascular heritage translates to protocol designs that address FDA Class III device requirements including anatomical compatibility demonstration, endothelialization assessment, and comprehensive safety validation.",Activity,Proven Structural Heart Regulatory Success,"Our data packages have supported successful FDA approvals for structural heart devices across LAA closure, septal defect, and transcatheter repair categories. We understand Class III device requirements including chronic biocompatibility demonstration through ISO 10993 compliance, deployment accuracy validation, and the specific endpoints FDA expects for structural heart device submissions.",Ready to Start Your Study?,"Our team is ready to discuss your structural heart device, regulatory pathway, and study requirements to optimize your path to FDA approval.",Schedule Consultation,https://harmonious-leadership-859682.framer.app/contact
arrhythmia-testing,Arrhythmia Device Testing | Synchrony Labs,Cardiovascular Disease Testing,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing,Arrhythmia Device Testing,"Comprehensive preclinical validation for cardiac rhythm management devices including pacemaker electrical performance testing, ICD defibrillation efficacy assessment, and lead system biocompatibility protocols under GLP compliance.",Complete Arrhythmia Device Testing Services,"We provide specialized testing for pacemaker and ICD platforms, addressing unique electrical performance, lead system, and biocompatibility requirements for each device category.",Heart,Pacemaker Testing,"Bradycardia pacing device validation including electrical performance characterization, sensing algorithm verification, lead system biocompatibility, and battery longevity assessment for single, dual, and biventricular platforms.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/arrhythmia-testing/pacemaker-testing,Zap,ICD Testing,"Implantable cardioverter defibrillator validation with arrhythmia detection algorithm testing, high-voltage defibrillation efficacy assessment, shock delivery characterization, and CRT-D system evaluation.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/arrhythmia-testing/icd-testing,,,,,,,,,,,,,,,,,,,,,,,,,What We Test,"Cardiac rhythm management devices sustain life through precise electrical therapy, requiring validation that demonstrates reliable sensing, appropriate pacing, and effective arrhythmia termination across varying physiological conditions. Pacemakers must detect intrinsic cardiac activity while delivering therapy that maintains adequate heart rate without depleting battery reserves prematurely. ICDs face the additional challenge of discriminating life-threatening ventricular arrhythmias from benign rhythms while delivering high-voltage therapy that terminates fibrillation without causing unnecessary shocks that traumatize patients and accelerate device replacement.

We evaluate electrical performance using specialized electrophysiology systems that capture pacing thresholds, sensing amplitudes, and impedance measurements with microsecond precision. Our catheterization laboratories feature programmable cardiac simulation systems, real-time rhythm analysis capabilities, and high-voltage testing infrastructure that characterizes defibrillation efficacy across multiple energy levels. From sensing algorithm validation to battery longevity projection, our protocols address the complex interaction between device electronics, lead systems, and cardiac tissue throughout chronic implantation periods.

ISO 14708 series standards guide cardiac device assessment while FDA guidance documents for active implantable medical devices inform protocol development. Whether validating leadless pacemaker platforms, MRI-conditional ICD systems, or cardiac resynchronization therapy devices, our GLP-compliant testing addresses both PMA pathway requirements and post-market surveillance objectives for Class III life-sustaining devices.",Key Testing Capabilities,Electrical Performance Characterization,"Pacing output validation across voltage and pulse width ranges, sensing threshold assessment for P-wave and R-wave detection, and impedance measurement throughout chronic implantation. Battery performance evaluation projects device longevity under varying pacing burden scenarios.",Arrhythmia Detection Algorithm Validation,"Detection sensitivity testing across ventricular tachycardia and fibrillation presentations, specificity assessment for supraventricular tachycardia rejection, and rate discrimination validation. Advanced algorithms including morphology analysis and sudden onset criteria undergo comprehensive evaluation.",Defibrillation Efficacy Assessment,"High-voltage testing characterizes defibrillation thresholds across multiple energy levels while waveform optimization validates biphasic shock delivery. Capacitor charging performance, shock impedance measurement, and therapy success rate analysis address ICD-specific requirements.",Lead System Performance and Durability,"Chronic electrical integrity assessment evaluates conductor resistance stability, insulation performance under flexion stress, and lead-tissue interface impedance changes. Mechanical durability protocols simulate years of cardiac motion through accelerated fatigue testing.",Electromagnetic Compatibility Testing,"MRI conditional validation per ISO 14117 standards, electromagnetic interference susceptibility assessment across frequency ranges, and medical device interaction testing. Evaluation includes exposure to electrocautery, defibrillators, and common consumer electronics.",Biocompatibility and Chronic Safety,"ISO 10993 testing adapted for active implantable devices addresses chronic tissue contact requirements. Specialized protocols evaluate hemocompatibility for blood-contacting components, muscle stimulation effects, and long-term tissue response at lead-myocardium interfaces.",Why Choose Synchrony for Arrhythmia Device Testing,Four decades of exclusive cardiovascular focus provides specialized electrophysiology infrastructure and proven regulatory expertise for cardiac rhythm management devices that generic facilities cannot match.,Microscope,Specialized Electrophysiology Infrastructure,"Two catheterization laboratories equipped specifically for cardiac rhythm device evaluation feature programmable cardiac simulation systems, high-resolution ECG monitoring, and real-time hemodynamic assessment capabilities. Our high-voltage testing infrastructure accommodates ICD defibrillation assessment while electromagnetic compatibility chambers validate MRI conditional devices and interference immunity across multiple frequency ranges.",Users,Cardiac Rhythm Device Expertise,"Founded by Duke University interventional cardiologists who pioneered electrophysiology techniques, our team understands cardiac conduction systems, pacing algorithms, and arrhythmia mechanisms specific to rhythm management devices. This cardiovascular heritage translates to protocol designs that address FDA Class III device requirements including sensing validation, battery longevity assessment, and the comprehensive safety testing life-sustaining devices demand.",CheckCircle,Proven Active Implant Regulatory Success,"Our data packages have supported successful FDA approvals for cardiac rhythm management devices across pacemaker, ICD, and CRT categories. We understand Class III active implantable medical device requirements including electromagnetic compatibility demonstration through ISO 14117 compliance, chronic biocompatibility validation, and the specific endpoints FDA expects for rhythm device submissions addressing both bradycardia management and sudden cardiac death prevention.",Ready to Start Your Study?,"Our team is ready to discuss your arrhythmia device, regulatory pathway, and study requirements to optimize your path to FDA approval.",Schedule Consultation,https://harmonious-leadership-859682.framer.app/contact
coronary-stent-testing,Coronary Stent Testing Services | Synchrony Labs,Cardiovascular Disease Testing,https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing,Coronary Stent Testing,"Comprehensive preclinical validation for drug-eluting and bare metal coronary stents with vascular healing assessment, drug elution characterization, and polymer biocompatibility evaluation.",Complete Coronary Stent Testing Services,"We provide specialized testing for drug-eluting stent platforms, addressing unique combination product requirements including drug release kinetics, polymer characterization, and vascular healing validation.",Pill,Drug-Eluting Stent Testing,"Comprehensive DES validation including drug release kinetics characterization, polymer coating assessment, tissue uptake quantification, and antiproliferative efficacy evaluation for combination product submissions.",https://harmonious-leadership-859682.framer.app/preclinical-services/cardiovascular-disease-testing/coronary-stent-testing/des-testing,,,,,,,,,,,,,,,,,,,,,,,,,,,,,What We Test,"Coronary stent development requires validation that addresses mechanical performance, biological safety, and therapeutic efficacy across diverse platform types. Drug-eluting stents face additional complexity as combination products requiring integrated assessment of device mechanics, polymer coating performance, and pharmacological activity. Whether validating bare metal platforms through radial strength and biocompatibility testing or characterizing drug-eluting systems with complex elution profiles, successful regulatory submissions demand comprehensive preclinical data addressing FDA expectations for both immediate performance and long-term vascular healing.

We evaluate mechanical integrity through radial force measurement, crush resistance assessment, and accelerated durability protocols that simulate years of cardiac loading. Our catheterization laboratories feature high-resolution fluoroscopy and intravascular ultrasound capabilities enabling deployment characterization in anatomically accurate coronary models. For drug-eluting platforms, specialized analytical systems quantify drug release kinetics through HPLC analysis while tissue distribution studies map therapeutic agent penetration patterns in vessel walls. Polymer coating assessment utilizes scanning electron microscopy and advanced imaging techniques identifying uniformity, adhesion characteristics, and structural integrity throughout deployment sequences.

ISO 10993 biocompatibility standards guide material evaluation while ISO 25539 specifications inform mechanical testing protocols for vascular stents. Drug-eluting platforms require additional FDA guidance consideration addressing combination product requirements, drug-specific toxicology, and polymer biocompatibility assessment. Our testing addresses both 510(k) substantial equivalence demonstrations and PMA pathway requirements for breakthrough technologies, providing complete validation packages supporting regulatory submissions across bare metal designs, established drug-eluting platforms, bioresorbable scaffolds, and novel therapeutic combinations.",Key Testing Capabilities,Mechanical Performance Validation,"Radial strength measurement across expansion ranges, recoil assessment following deployment, and fatigue durability testing through accelerated cardiac cycle simulation. Crush resistance protocols validate performance under external compression while deployment characterization addresses foreshortening, dog-boning, and uniform expansion profiles.",Drug Elution Characterization,"HPLC-based release kinetics quantification under physiological flow conditions, coating uniformity assessment through advanced microscopy, and tissue uptake validation measuring therapeutic agent distribution in arterial walls. Multi-phase elution profiling characterizes burst release, sustained delivery, and long-term drug availability patterns.",Vascular Healing Assessment,"Standardized histomorphometry measuring neointimal thickness, strut coverage progression, and inflammation scoring at multiple timepoints. Endothelialization studies track vessel healing while restenosis quantification evaluates lumen area preservation and late loss measurements addressing long-term patency.",Polymer Biocompatibility Testing,"ISO 10993-compliant evaluation addressing durable and biodegradable polymer systems, coating adhesion validation during balloon expansion, and degradation kinetics characterization for absorbable platforms. Specialized protocols assess polymer-drug interactions and coating integrity throughout shelf life and deployment.",Hemocompatibility and Thrombogenicity,"ISO 10993-4 blood contact testing quantifying platelet activation, complement cascade effects, and hemolysis indices for blood-contacting materials. Thrombogenicity assessment evaluates acute clot formation risk while chronic studies address late thrombosis potential requiring extended antiplatelet therapy.",Imaging Compatibility Validation,"MRI conditional testing per ASTM F2503 standards, radiopacity assessment ensuring fluoroscopic visualization, and artifact characterization for CT and MRI modalities. Intravascular ultrasound compatibility protocols validate post-implantation imaging capabilities essential for clinical follow-up assessment.",Why Choose Synchrony for Coronary Stent Testing,Four decades of exclusive cardiovascular focus provides specialized infrastructure and proven regulatory expertise for coronary stent platforms that generic facilities cannot match.,Microscope,Specialized Stent Testing Infrastructure,"Two catheterization laboratories equipped specifically for coronary device evaluation feature high-resolution fluoroscopy, IVUS integration, and hemodynamic monitoring systems. Advanced analytical capabilities include HPLC systems for drug elution analysis and scanning electron microscopy for coating characterization while specialized mechanical testing equipment validates radial strength and deployment mechanics.",Users,Coronary Device Development Expertise,"Founded by Duke University interventional cardiologists who pioneered minimally invasive coronary techniques, our team understands stent deployment mechanics, vascular healing patterns, and combination product challenges. This cardiovascular heritage translates to protocol designs addressing Class III device requirements including durability demonstration and comprehensive vascular healing validation.",CheckCircle,Proven Combination Product Regulatory Success,"Our data packages have supported successful FDA approvals for coronary stents across bare metal, drug-eluting, and bioresorbable categories. We understand combination product requirements including CDRH-CDER coordination and the comprehensive preclinical evidence FDA expects for both 510(k) and PMA pathway submissions.",Ready to Start Your Study?,"Our team is ready to discuss your coronary stent platform, regulatory pathway, and study requirements to optimize your path to FDA approval.",Schedule Consultation,https://harmonious-leadership-859682.framer.app/contact